The enforcement scale is real: more than 455 FDA adverse-event reports tied to compounded semaglutide, over 50 warning letters to compounded GLP-1 sellers in 2025, and 30-plus more in March 2026, several of them naming the compounding pharmacies behind telehealth brands
Most of whats known comes from anecdotal reports, online communities, and a small number of observational accounts rather than controlled trials
Cottrell JJ, Stoll B, Buddington RK, Stephens JE, Cui L, Chang X, et al
Some people take BPC157 by mouth for stomach issues, but we do not have good data on how well that works
LY3298176 resulted in remarkable jaw dropping reduction in HbA1c and body weight
Whether that translates into a noticeable benefit depends on why you are taking it